1/6/2025

Heparin Lock Flush Syringes

Products Affected - Description

- BD Posiflush, BD, 10 unit/mL, 3 mL fill in 3 mL syringe, 30 count, NDC 08290-3064-13
- BD Posiflush, BD, 10 unit/mL, 5 mL fill in 5 mL syringe, 30 count, NDC 08290-3064-14
- BD Posiflush, BD, 100 unit/mL, 5 mL fill in 5 mL syringe, 30 count, NDC 08290-3064-24
- Heparin Sodium, BBraun, 100 unit/mL, 5 mL syringe, 1,000 count, NDC 63807-0600-05 - discontinued
- Heparin Sodium, Medefil, Inc., 10 unit/mL, 1 mL fill in 6 mL prefilled syringe, NDC 64253-0222-21
- Heparin Sodium, Medefil, Inc., 10 unit/mL, 3 mL fill in 12 mL prefilled syringe, NDC 64253-0222-33
- Heparin Sodium, Medefil, Inc., 10 unit/mL, 3 mL fill in 6 mL prefilled syringe, NDC 64253-0222-23
- Heparin Sodium, Medefil, Inc., 10 unit/mL, 5 mL fill in 12 mL prefilled syringe, NDC 64253-0222-35
- Heparin Sodium, Medefil, Inc., 100 unit/mL, 3 mL fill in 6 mL prefilled syringe, NDC 64253-0333-23
- Heparin Sodium, Medefil, Inc., 100 unit/mL, 5 mL fill in 12 mL prefilled syringe, NDC 64253-0333-35

Reason for the Shortage

- BBraun discontinued heparin lock flush syringes.
- BD Medical did not provide a reason for the shortage.
- Medefil did not provide a reason for the shortage.

Available Products

- Heparin Sodium, Medefil, Inc., 100 unit/mL, 1 mL fill in 6 mL prefilled syringe, NDC 64253-0333-21
- Heparin Sodium, Medefil, Inc., 100 unit/mL, 3 mL fill in 12 mL prefilled syringe, NDC 64253-0333-33

Estimated Resupply Dates

- BD Medical has Posiflush syringes on allocation.
- Medefil has most heparin lock flush syringes on back order and the company cannot estimate a release date.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.